Safety and Efficacy Study of Pemetrexed + Platinum Chemotherapy + Pembrolizumab (MK-3475) With or Without Lenvatinib (MK-7902/E7080) as First-line Intervention in Adults With Metastatic Nonsquamous Non-small Cell Lung Cancer (MK-7902-006/E7080-G000-315/LEAP-006)-China Extension Study
Clinical trial NCT04716933 · COMPLETED
Trial details
- NCT number
- NCT04716933
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-11-05
- Primary completion
- 2023-08-11
- Enrollment
- 201
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.